The innate cellular responses to HIV-1 invasion: Emerging molecules of ancient defense mechanisms

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 3, 2007, Pages 131-138

  Simm, Malgorzata ^a  

^a Columbia University ^*  (United States)

Author keywords

Antiviral factors; CD4+ T cells; CD8+ T cells; Innate immunity

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; DEFENSE MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNITY, NATURAL; LYMPHOKINES;

EID: 34250786654     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0023-9     Document Type: Review

References (76)

1. Abdelwahab S. F., Cocchi F., Bagley K. C., Kamin-Lewis R., Gallo R. C., DeVico A. and Lewis G. K. (2003): HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses. Proc. Natl. Acad. Sci. USA, 100, 15006-15010.
2. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M. and Berger E. A. (1996): CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955-1958.
3. Barker E., Bossart K. N., Locher C. P., Patterson B. K. and Levy J. A. (1996): CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J. Gen. Virol., 77 (Pt 12), 2953-2962.
4. Barker T. D., Weissman D., Daucher J. A., Roche K. M. and Fauci A. S. (1996): Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. J. Immunol., 156, 4476-4483.
5. Berger E. A., Murphy P. M. and Farber J. M. (1999): Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol., 17, 657-700.
6. Birkemo G. A., Luders T., Andersen O., Nes I. F. and Nissen-Meyer J. (2003): Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). Biochim. Biophys. Acta, 1646, 207-215.
7. Biron C. A., Nguyen K. B., Pien G. C., Cousens L. P. and Salazar-Mather T. P. (1999): Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol., 17, 189-220.
8. Blackbourn D. J., Mackewicz C. E., Barker E., Hunt T. K., Herndier B., Haase A. T. and Levy J. A. (1996): Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc. Natl. Acad. Sci. USA, 93, 13125-13130.
9. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J. and Springer T. A. (1996): The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829-833.
10. Chang T. L., Mosoian A., Pine R., Klotman M. E. and Moore J. P. (2002): A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J. Virol., 76, 569-581.
11. Chen Y., Dampf D., Chen M., Kulka K., Volsky D. J., Saha K. and Gupta P. (2000): Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines. AIDS Res. Hum. Retroviruses, 16, 117-124.
12. Chernukhin I. V., Shamsuddin S., Robinson A. F., Carne A. F., Paul A., El-Kady A. I., Lobanenkov V. V. and Klenova E. M. (2000): Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J. Biol. Chem., 275, 29915-29921.
13. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C. and Sodroski J. (1996): The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 85, 1135-1148.
14. Choe W., Volsky D. J. and Potash M. J. (2001): Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J. Virol., 75, 10738-10745.
15. Choe W., Volsky D. J. and Potash M. J. (2002): Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages. J. Virol., 76, 5274-5277.
16. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C. and Lusso P. (1995): Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science, 270, 1811-1815.
17. Cota M., Mengozzi M., Vicenzi E., Panina-Bordignon P., Sinigaglia F., Transidico P., Sozzani S., Mantovani A. and Poli G. (2000): Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc. Natl. Acad. Sci. USA, 97, 9162-9167.
18. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R. and Landau N. R. (1996): Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381, 661-666.
19. Deng H. K., Unutmaz D., KewalRamani V. N. and Littman D. R. (1997): Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature, 388, 296-300.
20. DeVico A. L. and Gallo R. C. (2004): Control of HIV-1 infection by soluble factors of the immune response. Nat. Rev. Microbiol., 2, 401-413.
21. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P. and Paxton W. A. (1996): HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381, 667-673.
22. Dragic T., Trkola A., Lin S. W., Nagashima K. A., Kajumo F., Zhao L., Olson W. C., Wu L., Mackay C. R., Allaway G. P., Sakmar T. P., Moore J. P. and Maddon P. J. (1998): Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol., 72, 279-285.
23. Drueppel L., Pfleiderer K., Schmidt A., Hillen W. and Berens C. (2004): A short autonomous repression motif is located within the N-terminal domain of CTCF. FEBS Lett., 572, 154-158.
24. Dunn K. L. and Davie J. R. (2003): The many roles of the transcriptional regulator CTCF. Biochem. Cell Biol., 81, 161-167.
25. Fernandes J. M., Kemp G. D., Molle M. G. and Smith V. J. (2002): Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. Biochem. J., 368, 611-620.
26. Filippova G. N., Fagerlie S., Klenova E. M., Myers C., Dehner Y., Goodwin G., Neiman P. E., Collins S. J. and Lobanenkov V. V. (1996): An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell Biol., 16, 2802-2813.
27. Furci L., Lopalco L., Loverro P., Sinnone M., Tambussi G., Lazzarin A. and Lusso P. (2002): Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals. AIDS, 16, 1003-1008.
28. Garcia-Sastre A. and Biron C. A. (2006): Type 1 interferons and the virus-host relationship: a lesson in detente. Science, 312, 879-882.
29. Geiben-Lynn R., Kursar M., Brown N. V., Kerr E. L., Luster A. D. and Walker B. D. (2001): Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines. J. Virol., 75, 8306-8316.
30. Hannappel E. and Huff T. (2003): The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam. Horm., 66, 257-296.
31. Hilleman M. R. (1989): Conclusions: in pursuit of an AIDS virus vaccine. Immunol. Ser., 44, 605-620.
32. Kartvelishvili A., Lesner A., Szponar M. and Simm M. (2004): Microarray analysis of differentially expressed genes in cells resistant to HIV-1. Immunol. Lett., 93, 79-86.
33. Kim H. S., Yoon H., Minn I., Park C. B., Lee W. T., Zasloff M. and Kim S. C. (2000): Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. J. Immunol., 165, 3268-3274.
34. Klenova E. M., Morse H. C. 3rd, Ohlsson R. and Lobanenkov V. V. (2002): The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin. Cancer Biol., 12, 399-414.
35. Korth M. J., Taylor M. D. and Katze M. G. (1998): Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms. Virology, 247, 265-273.
36. Lehrer R. I., Lichtenstein A. K. and Ganz T. (1993): Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol., 11, 105-128.
37. Leith J. G., Copeland K. F., McKay P. J., Bienzle D., Richards C. D. and Rosenthal K. L. (1999): T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication. AIDS Res. Hum. Retroviruses, 15, 1553-1561.
38. Lesner A., Kartvelishvili A., Lesniak J., Nikolov D., Kartvelishvili M., Trillo-Pazos G., Zablotna E. and Simm M. (2004): Monoubiquitinated histone H1B is required for antiviral protection in CD4(+)T cells resistant to HIV-1. Biochemistry, 43, 16203-16211.
39. Lesner A., Li Y., Nitkiewicz J., Li G., Kartvelishvili A., Kartvelishvili M. and Simm M. (2005): A soluble factor secreted by an HIV-1-resistant cell line blocks transcription through inactivating the DNA-binding capacity of the NF-kappa B p65/p50 dimer. J. Immunol., 175, 2548-2554.
40. Levy J. A., Mackewicz C. E. and Barker E. (1996): Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today, 17, 217-224.
41. Li G., Aaron S., Kazmierczak K., Lesner A., Li Y., Ivanova A., Bentsman G., Potash M. J. and Simm M. (2007): Soluble products of HIV-1 resistant factor (HRF)+ cells induce production of an HRF-like anti NF-κB activity by human macrophages that TNF-α production in response to HIV-1 and bacterial stimuli. Immunol. Cell Biol. (in press)
42. Li Y., Li G., Sagiv A., Ivanowa A. and Simm M. (2007): Critical role of CTCF mRNA up-regulation in the induction of innate responses to HIV-1 in CD4+ T cells. Virology (submitted).
43. Mackewicz C. E., Blackbourn D. J. and Levy J. A. (1995): CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA, 92, 2308-2312.
44. Mackewicz C. E., Craik C. S. and Levy J. A. (2003): The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proc. Natl. Acad. Sci. USA, 100, 3433-3438.
45. Mackewicz C. and Levy J. A. (1992): CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses, 8, 1039-1050.
46. Mackewicz C. E., Yuan J., Tran P., Diaz L., Mack E., Selsted M. E. and Levy J. A. (2003): alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS, 17, F23-32.
47. Mantovani A., Gray P. A., Van Damme J. and Sozzani S. (2000): Macrophage-derived chemokine (MDC). J. Leukoc. Biol., 68, 400-404.
48. Mosoian A., Teixeira A., Caron E., Piwoz J. and Klotman M. E. (2000): CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines. Viral Immunol., 13, 481-495.
49. Mosoian A., Teixeira A., High A. A., Christian R. E., Hunt D. F., Shabanowitz J., Liu X. and Klotman M. (2006): Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J. Virol., 80, 9200-9206.
50. Ohlsson R., Renkawitz R. and Lobanenkov V. (2001): CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet., 17, 520-527.
51. Pal R., Garzino-Demo A., Markham P. D., Burns J., Brown M., Gallo R. C. and DeVico A. L. (1997): Inhibition of HIV-1 infection by the beta-chemokine MDC. Science, 278, 695-698.
52. Park I. Y., Park C. B., Kim M. S. and Kim S. C. (1998): Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett., 437, 258-262.
53. Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnick J., VanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M. and Koup R. A. (1996): Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med., 2, 412-417.
54. Power C. A. and Wells T. N. (1996): Cloning and characterization of human chemokine receptors. Trends Pharmacol. Sci., 17, 209-213.
55. Richards R. C., O'Neil D. B., Thibault P. and Ewart K. V. (2001): Histone H1: an antimicrobial protein of Atlantic salmon (Salmo salar). Biochem. Biophys. Res. Commun., 284, 549-555.
56. Saha K., Volsky D. J. and Matczak E. (1999): Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry. J. Virol., 73, 7891-7898.
57. Samuel C. E. (1991): Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology, 183, 1-11.
58. Schall T. J., Bacon K., Toy K. J. and Goeddel D. V. (1990): Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature, 347, 669-671.
59. Schonwetter B. S., Stolzenberg E. D. and Zasloff M. A. (1995): Epithelial antibiotics induced at sites of inflammation. Science, 267, 1645-1648.
60. Selin L. K., Santolucito P. A., Pinto A. K., Szomolanyi-Tsuda E. and Welsh R. M. (2001): Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J. Immunol., 166, 6784-6794.
61. Simm M., Miller L. S., Durkin H. G., Allen M., Chao W., Lesner A., Potash M. J. and Volsky D. J. (2002): Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection. Virology, 294, 1-12.
62. Simm M., Pekarskaya O., Potash M. J. and Volsky D. J. (2000): Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. AIDS Res. Hum. Retroviruses, 16, 943-952.
63. Skrygan M., Schafer H., Schmidt C., Schmidt W. E. and Bastian A. (2003): Inhibition of adenovirus infection by the bronchoalveolar lavage supernatant in vitro. Eur. J. Med. Res., 8, 519-524.
64. Taniguchi T., Ogasawara K., Takaoka A. and Tanaka N. (2001): IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol., 19, 623-655.
65. Taub D. D., Proost P., Murphy W. J., Anver M., Longo D. L., van Damme J. and Oppenheim J. J. (1995): Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest., 95, 1370-1376.
66. Van Damme J., Proost P., Lenaerts J. P. and Opdenakker G. (1992): Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med., 176, 59-65.
67. Walker C. M. and Levy J. A. (1989): A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology, 66, 628-630.
68. Walker C. M., Moody D. J., Stites D. P. and Levy J. A. (1986): CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science, 234, 1563-1566.
69. Wallace M., Malkovsky M. and Carding S. R. (1995): Gamma/delta T lymphocytes in viral infections. J. Leukoc. Biol., 58, 277-283.
70. Wang Y., Griffiths W. J., Jornvall H., Agerberth B. and Johansson J. (2002): Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A. Eur. J. Biochem., 269, 512-518.
71. Welsh R. M., Lin M. Y., Lohman B. L., Varga S. M., Zarozinski C. C. and Selin L. K. (1997): Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections. Immunol. Rev., 159, 79-93.
72. Wiviott L. D., Walker C. M. and Levy J. A. (1990): CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell. Immunol., 128, 628-634.
73. Yang D., Biragyn A., Hoover D. M., Lubkowski J. and Oppenheim J. J. (2004): Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol., 22, 181-215.
74. Yang D., Biragyn A., Kwak L. W. and Oppenheim J.,J. (2002): Mammalian defensins in immunity: more than just microbicidal. Trends Immunol., 23, 291-296.
75. Zhang L., Lopez P., He T., Yu W. and Ho D. D. (2004): Retraction of an interpretation. Science, 303, 467.
76. Zhang L., Yu W., He T., Yu J., Caffrey R. E., Dalmasso E. A., Fu S., Pham T., Mei J., Ho J. J., Zhang W., Lopez P. and Ho D. D. (2002): Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8-antiviral factor. Science, 298, 995-1000.